Approximately 5 to 10% of women with breast cancer carry a deleterious mutation in BRCA1 or BRCA2 (BRCA1/2 hereafter) [2–4] and may be at an increased risk for recurrence of breast cancer in the same or opposite breast [5–8]. This evidence concerns the gene BRCA1 and breast carcinoma.